MiniMed Group Statistics
Total Valuation
MiniMed Group has a market cap or net worth of $4.00 billion. The enterprise value is $4.05 billion.
Important Dates
The next estimated earnings date is Monday, August 10, 2026, after market close.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MiniMed Group has 280.82 million shares outstanding.
| Current Share Class | 280.82M |
| Shares Outstanding | 280.82M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +6.05% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 11.60% |
| Float | 28.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 21.61 |
| PS Ratio | 1.29 |
| Forward PS | 1.17 |
| PB Ratio | 1.16 |
| P/TBV Ratio | 3.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -9.28% and return on invested capital (ROIC) is -3.11%.
| Return on Equity (ROE) | -9.28% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -3.11% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $387,750 |
| Profits Per Employee | -$41,375 |
| Employee Count | 8,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MiniMed Group has paid $128.00 million in taxes.
| Income Tax | 128.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 12.93 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 54.34 |
| Average Volume (20 Days) | 1,279,482 |
Short Selling Information
The latest short interest is 4.04 million, so 1.44% of the outstanding shares have been sold short.
| Short Interest | 4.04M |
| Short Previous Month | 4.28M |
| Short % of Shares Out | 1.44% |
| Short % of Float | 14.43% |
| Short Ratio (days to cover) | 6.39 |
Income Statement
In the last 12 months, MiniMed Group had revenue of $3.10 billion and -$331.00 million in losses. Loss per share was -$1.29.
| Revenue | 3.10B |
| Gross Profit | 1.68B |
| Operating Income | -172.00M |
| Pretax Income | -187.00M |
| Net Income | -331.00M |
| EBITDA | -16.00M |
| EBIT | -172.00M |
| Loss Per Share | -$1.29 |
Full Income Statement Balance Sheet
The company has $10.00 million in cash and $61.00 million in debt, giving a net cash position of -$51.00 million or -$0.18 per share.
| Cash & Cash Equivalents | 10.00M |
| Total Debt | 61.00M |
| Net Cash | -51.00M |
| Net Cash Per Share | -$0.18 |
| Equity (Book Value) | 3.46B |
| Book Value Per Share | 12.33 |
| Working Capital | n/a |
Full Balance Sheet Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 156.00M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 54.16%, with operating and profit margins of -5.54% and -10.67%.
| Gross Margin | 54.16% |
| Operating Margin | -5.54% |
| Pretax Margin | -6.03% |
| Profit Margin | -10.67% |
| EBITDA Margin | -0.52% |
| EBIT Margin | -5.54% |
| FCF Margin | n/a |